Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Mitochondrial DNA variations and mitochondrial dysfunction in Fanconi anemia.

Solanki A, Rajendran A, Mohan S, Raj R, Vundinti BR.

PLoS One. 2020 Jan 15;15(1):e0227603. doi: 10.1371/journal.pone.0227603. eCollection 2020.

2.

The Use of High-Throughput Transcriptomics to Identify Pathways with Therapeutic Significance in Podocytes.

Solanki AK, Srivastava P, Rahman B, Lipschutz JH, Nihalani D, Arif E.

Int J Mol Sci. 2019 Dec 31;21(1). pii: E274. doi: 10.3390/ijms21010274.

3.

Interfacial Mechanism for Efficient Resistive Switching in Ruddlesden-Popper Perovskites for Non-volatile Memories.

Solanki A, Guerrero A, Zhang Q, Bisquert J, Sum TC.

J Phys Chem Lett. 2020 Jan 16;11(2):463-470. doi: 10.1021/acs.jpclett.9b03181. Epub 2020 Jan 3.

PMID:
31873017
4.

Correlation of Dermoscopic and Histopathologic Patterns in Leprosy - A Pilot Study.

Chopra A, Mitra D, Agarwal R, Saraswat N, Talukdar K, Solanki A.

Indian Dermatol Online J. 2019 Nov 1;10(6):663-668. doi: 10.4103/idoj.IDOJ_297_18. eCollection 2019 Nov-Dec.

5.

Hot carrier extraction in CH3NH3PbI3 unveiled by pump-push-probe spectroscopy.

Lim SS, Giovanni D, Zhang Q, Solanki A, Jamaludin NF, Lim JWM, Mathews N, Mhaisalkar S, Pshenichnikov MS, Sum TC.

Sci Adv. 2019 Nov 15;5(11):eaax3620. doi: 10.1126/sciadv.aax3620. eCollection 2019 Nov.

6.

EDITORIAL COMMENT.

Solanki AA, Efstathiou JA.

Urology. 2019 Nov;133:171-172. doi: 10.1016/j.urology.2019.05.063. No abstract available.

PMID:
31706416
7.

Electrostatically Doped Silicon Nanowire Arrays for Multispectral Photodetectors.

Um HD, Solanki A, Jayaraman A, Gordon RG, Habbal F.

ACS Nano. 2019 Oct 22;13(10):11717-11725. doi: 10.1021/acsnano.9b05659. Epub 2019 Oct 7.

PMID:
31577128
8.

A founder variant in the South Asian population leads to a high prevalence of FANCL Fanconi anemia cases in India.

Donovan FX, Solanki A, Mori M, Chavan N, George M, C SK, Okuno Y, Muramastsu H, Yoshida K, Shimamoto A, Takaori-Kondo A, Yabe H, Ogawa S, Kojima S, Yabe M, Ramanagoudr-Bhojappa R, Smogorzewska A, Mohan S, Rajendran A, Auerbach AD, Takata M, Chandrasekharappa SC, Vundinti BR.

Hum Mutat. 2020 Jan;41(1):122-128. doi: 10.1002/humu.23914. Epub 2019 Sep 26.

PMID:
31513304
9.

Mutations in KIRREL1, a slit diaphragm component, cause steroid-resistant nephrotic syndrome.

Solanki AK, Widmeier E, Arif E, Sharma S, Daga A, Srivastava P, Kwon SH, Hugo H, Nakayama M, Mann N, Majmundar AJ, Tan W, Gee HY, Sadowski CE, Rinat C, Becker-Cohen R, Bergmann C, Rosen S, Somers M, Shril S, Huber TB, Mane S, Hildebrandt F, Nihalani D.

Kidney Int. 2019 Oct;96(4):883-889. doi: 10.1016/j.kint.2019.06.016. Epub 2019 Jul 10.

PMID:
31472902
10.

A resistance-sensing mechanical injector for the precise delivery of liquids to target tissue.

Chitnis GD, Verma MKS, Lamazouade J, Gonzalez-Andrades M, Yang K, Dergham A, Jones PA, Mead BE, Cruzat A, Tong Z, Martyn K, Solanki A, Landon-Brace N, Karp JM.

Nat Biomed Eng. 2019 Aug;3(8):621-631. doi: 10.1038/s41551-019-0350-2. Epub 2019 Feb 25.

11.

Sonic Hedgehog Is a Determinant of γδ T-Cell Differentiation in the Thymus.

Mengrelis K, Lau CI, Rowell J, Solanki A, Norris S, Ross S, Ono M, Outram S, Crompton T.

Front Immunol. 2019 Jul 19;10:1629. doi: 10.3389/fimmu.2019.01629. eCollection 2019.

12.

The Impact of Transitioning to Prospective Contouring and Planning Rounds as Peer Review.

Surucu M, Bajaj A, Roeske JC, Block AM, Price J, Small W Jr, Solanki AA.

Adv Radiat Oncol. 2019 Mar 21;4(3):532-540. doi: 10.1016/j.adro.2019.03.004. eCollection 2019 Jul-Sep.

13.

Immunization with recombinant fusion of LTB and linear epitope (40-62) of epsilon toxin elicits protective immune response against the epsilon toxin of Clostridium perfringens type D.

Kaushik H, Deshmukh SK, Solanki AK, Bhatia B, Tiwari A, Garg LC.

AMB Express. 2019 Jul 12;9(1):105. doi: 10.1186/s13568-019-0824-3.

14.

Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation.

Papaioannou E, Yánez DC, Ross S, Lau CI, Solanki A, Chawda MM, Virasami A, Ranz I, Ono M, O'Shaughnessy RFL, Crompton T.

J Clin Invest. 2019 Jul 2;129(8):3153-3170. doi: 10.1172/JCI125170. eCollection 2019 Jul 2.

15.

Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury.

Arif E, Solanki AK, Srivastava P, Rahman B, Fitzgibbon WR, Deng P, Budisavljevic MN, Baicu CF, Zile MR, Megyesi J, Janech MG, Kwon SH, Collier J, Schnellmann RG, Nihalani D.

Kidney Int. 2019 Sep;96(3):656-673. doi: 10.1016/j.kint.2019.03.023. Epub 2019 May 6.

PMID:
31262488
16.

Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer.

Savir-Baruch B, Lovrec P, Solanki AA, Adams WH, Yonover PM, Gupta G, Schuster DM.

AJR Am J Roentgenol. 2019 Oct;213(4):851-858. doi: 10.2214/AJR.19.21153. Epub 2019 Jun 19.

PMID:
31216198
17.

"Dual Disease" TgAD/GSS mice exhibit enhanced Alzheimer's disease pathology and reveal PrPC-dependent secretion of Aβ.

Qin K, Zhao L, Gregory C, Solanki A, Mastrianni JA.

Sci Rep. 2019 Jun 12;9(1):8524. doi: 10.1038/s41598-019-44317-w.

18.

Solution-Processed Lead Iodide for Ultrafast All-Optical Switching of Terahertz Photonic Devices.

Manjappa M, Solanki A, Kumar A, Sum TC, Singh R.

Adv Mater. 2019 Aug;31(32):e1901455. doi: 10.1002/adma.201901455. Epub 2019 Jun 11.

PMID:
31183925
19.

Role of Water in Suppressing Recombination Pathways in CH3NH3PbI3 Perovskite Solar Cells.

Solanki A, Lim SS, Mhaisalkar S, Sum TC.

ACS Appl Mater Interfaces. 2019 Jul 17;11(28):25474-25482. doi: 10.1021/acsami.9b00793. Epub 2019 Jul 1.

PMID:
31179683
20.

The motor protein Myo1c regulates transforming growth factor-β-signaling and fibrosis in podocytes.

Arif E, Solanki AK, Srivastava P, Rahman B, Tash BR, Holzman LB, Janech MG, Martin R, Knölker HJ, Fitzgibbon WR, Deng P, Budisavljevic MN, Syn WK, Wang C, Lipschutz JH, Kwon SH, Nihalani D.

Kidney Int. 2019 Jul;96(1):139-158. doi: 10.1016/j.kint.2019.02.014. Epub 2019 Mar 4.

PMID:
31097328
21.

Disruption of the exocyst induces podocyte loss and dysfunction.

Nihalani D, Solanki AK, Arif E, Srivastava P, Rahman B, Zuo X, Dang Y, Fogelgren B, Fermin D, Gillies CE, Sampson MG, Lipschutz JH.

J Biol Chem. 2019 Jun 28;294(26):10104-10119. doi: 10.1074/jbc.RA119.008362. Epub 2019 May 9.

PMID:
31073028
22.

Multiscale analyses reveal native-like lamellar bone repair and near perfect bone-contact with porous strontium-loaded bioactive glass.

Autefage H, Allen F, Tang HM, Kallepitis C, Gentleman E, Reznikov N, Nitiputri K, Nommeots-Nomm A, O'Donnell MD, Lange C, Seidt BM, Kim TB, Solanki AK, Tallia F, Young G, Lee PD, Pierce BF, Wagermaier W, Fratzl P, Goodship A, Jones JR, Blunn G, Stevens MM.

Biomaterials. 2019 Jul;209:152-162. doi: 10.1016/j.biomaterials.2019.03.035. Epub 2019 Mar 25.

23.

Anle138b prevents PrP plaque accumulation in Tg(PrP-A116V) mice but does not mitigate clinical disease.

Qin K, Zhao L, Solanki A, Busch C, Mastrianni J.

J Gen Virol. 2019 Jun;100(6):1027-1037. doi: 10.1099/jgv.0.001262. Epub 2019 May 2.

PMID:
31045489
24.

Rheological Characterization of Biomaterials Directs Additive Manufacturing of Strontium-Substituted Bioactive Glass/Polycaprolactone Microfibers.

Paxton NC, Ren J, Ainsworth MJ, Solanki AK, Jones JR, Allenby MC, Stevens MM, Woodruff MA.

Macromol Rapid Commun. 2019 Jun;40(11):e1900019. doi: 10.1002/marc.201900019. Epub 2019 Apr 1.

PMID:
30932256
25.

Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies.

Solanki AA, Bossi A, Efstathiou JA, Lock D, Mondini M, Ramapriyan R, Welsh J, Kang J.

Eur Urol Oncol. 2019 Feb;2(1):79-87. doi: 10.1016/j.euo.2018.09.013. Epub 2018 Nov 16. Review.

PMID:
30929848
26.

NRG brain tumor specialists consensus guidelines for glioblastoma contouring.

Kruser TJ, Bosch WR, Badiyan SN, Bovi JA, Ghia AJ, Kim MM, Solanki AA, Sachdev S, Tsien C, Wang TJC, Mehta MP, McMullen KP.

J Neurooncol. 2019 May;143(1):157-166. doi: 10.1007/s11060-019-03152-9. Epub 2019 Mar 19.

PMID:
30888558
27.

Tunable Ferroelectricity in Ruddlesden-Popper Halide Perovskites.

Zhang Q, Solanki A, Parida K, Giovanni D, Li M, Jansen TLC, Pshenichnikov MS, Sum TC.

ACS Appl Mater Interfaces. 2019 Apr 10;11(14):13523-13532. doi: 10.1021/acsami.8b21579. Epub 2019 Apr 1.

PMID:
30854841
28.

Author Correction: Indirect tail states formation by thermal-induced polar fluctuations in halide perovskites.

Wu B, Yuan H, Xu Q, Steele JA, Giovanni D, Puech P, Fu J, Ng YF, Jamaludin NF, Solanki A, Mhaisalkar S, Mathews N, Roeffaers MBJ, Grätzel M, Hofkens J, Sum TC.

Nat Commun. 2019 Mar 5;10(1):1145. doi: 10.1038/s41467-019-09172-3.

29.

Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.

Srivastava P, Solanki AK, Arif E, Wolf BJ, Janech MG, Budisavljevic MN, Kwon SH, Nihalani D.

Kidney Int. 2019 Mar;95(3):708-716. doi: 10.1016/j.kint.2018.10.030. Epub 2019 Jan 29.

PMID:
30709661
30.

Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions.

Solanki AA, Mysz ML, Patel R, Surucu M, Kang H, Plypoo A, Bajaj A, Korpics M, Martin B, Hentz C, Gupta G, Farooq A, Baldea KG, Pawlowski J, Roeske J, Flanigan R, Small W, Harkenrider MM.

Adv Radiat Oncol. 2018 Oct 23;4(1):103-111. doi: 10.1016/j.adro.2018.10.004. eCollection 2019 Jan-Mar.

31.

Indirect tail states formation by thermal-induced polar fluctuations in halide perovskites.

Wu B, Yuan H, Xu Q, Steele JA, Giovanni D, Puech P, Fu J, Ng YF, Jamaludin NF, Solanki A, Mhaisalkar S, Mathews N, Roeffaers MBJ, Grätzel M, Hofkens J, Sum TC.

Nat Commun. 2019 Jan 29;10(1):484. doi: 10.1038/s41467-019-08326-7. Erratum in: Nat Commun. 2019 Mar 5;10(1):1145.

32.

β-cyclodextrin based dual-responsive multifunctional nanotheranostics for cancer cell targeting and dual drug delivery.

Das M, Solanki A, Joshi A, Devkar R, Seshadri S, Thakore S.

Carbohydr Polym. 2019 Feb 15;206:694-705. doi: 10.1016/j.carbpol.2018.11.049. Epub 2018 Nov 20.

PMID:
30553374
33.

Physical-chemical interactions between pharmaceuticals and biochar in synthetic and real urine.

Solanki A, Boyer TH.

Chemosphere. 2019 Mar;218:818-826. doi: 10.1016/j.chemosphere.2018.11.179. Epub 2018 Nov 27.

PMID:
30508800
34.

A Novel CLCN5 Mutation Associated With Focal Segmental Glomerulosclerosis and Podocyte Injury.

Solanki AK, Arif E, Morinelli T, Wilson RC, Hardiman G, Deng P, Arthur JM, Velez JC, Nihalani D, Janech MG, Budisavljevic MN.

Kidney Int Rep. 2018 Jun 18;3(6):1443-1453. doi: 10.1016/j.ekir.2018.06.003. eCollection 2018 Nov.

35.

Humanin Nanoparticles for Reducing Pathological Factors Characteristic of Age-Related Macular Degeneration.

Solanki A, Smalling R, Parola AH, Nathan I, Kasher R, Pathak Y, Sutariya V.

Curr Drug Deliv. 2019;16(3):226-232. doi: 10.2174/1567201815666181031163111.

PMID:
30381074
36.

IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammation.

Yánez DC, Sahni H, Ross S, Solanki A, Lau CI, Papaioannou E, Barbarulo A, Powell R, Lange UC, Adams DJ, Barenco M, Ono M, D'Acquisto F, Furmanski AL, Crompton T.

Eur J Immunol. 2019 Jan;49(1):66-78. doi: 10.1002/eji.201847692. Epub 2018 Nov 9.

37.

Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.

Silva SR, Gliniewicz A, Martin B, Prabhu VC, Germanwala AV, Melian E, Jones GA, Solanki AA.

World Neurosurg. 2019 Feb;122:e342-e348. doi: 10.1016/j.wneu.2018.10.044. Epub 2018 Oct 13.

PMID:
30326310
38.

Targeting miRNAs with CRISPR/Cas9 to Improve Recombinant Protein Production of CHO Cells.

Kellner K, Solanki A, Amann T, Lao N, Barron N.

Methods Mol Biol. 2018;1850:221-235. doi: 10.1007/978-1-4939-8730-6_15.

PMID:
30242690
39.

Targeting Matrix Metalloproteinases for Diabetic Retinopathy: The Way Ahead?

Solanki A, Bhatt LK, Johnston TP, Prabhavalkar KS.

Curr Protein Pept Sci. 2019;20(4):324-333. doi: 10.2174/1389203719666180914093109. Review.

PMID:
30215334
40.

Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary Report.

Kelly SJ, Hirani A, Shahidadpury V, Solanki A, Halasz K, Varghese Gupta S, Madow B, Sutariya V.

Biomedicines. 2018 Sep 11;6(3). pii: E92. doi: 10.3390/biomedicines6030092.

41.

Impaired transmissibility of atypical prions from genetic CJDG114V.

Cali I, Mikhail F, Qin K, Gregory C, Solanki A, Martinez MC, Zhao L, Appleby B, Gambetti P, Norstrom E, Mastrianni JA.

Neurol Genet. 2018 Aug 7;4(4):e253. doi: 10.1212/NXG.0000000000000253. eCollection 2018 Aug.

42.

Foxa1 and Foxa2 in thymic epithelial cells (TEC) regulate medullary TEC and regulatory T-cell maturation.

Lau CI, Yánez DC, Solanki A, Papaioannou E, Saldaña JI, Crompton T.

J Autoimmun. 2018 Sep;93:131-138. doi: 10.1016/j.jaut.2018.07.009. Epub 2018 Jul 27.

43.

Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent.

Son CH, Liauw SL, Hasan Y, Solanki AA.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):304-313. doi: 10.1016/j.ijrobp.2018.06.007. Epub 2018 Aug 7.

PMID:
29908944
44.

Isolated Langerhans Cell Histiocytosis of Orbit: A Case Report and Review of the Literature.

Naik M, Mehta A, Mehrotra N, Solanki A.

Case Rep Ophthalmol Med. 2018 Apr 4;2018:1529281. doi: 10.1155/2018/1529281. eCollection 2018.

45.

Effect of Red Blood Cell Storage Duration on Outcome After Paediatric Cardiac Surgery: A Prospective Observational Study.

Bishnoi AK, Garg P, Patel K, Ananthanarayanan C, Shah R, Solanki A, Pandya H, Patel S.

Heart Lung Circ. 2019 May;28(5):784-791. doi: 10.1016/j.hlc.2018.03.012. Epub 2018 Mar 31.

PMID:
29706495
46.

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017.

Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR Jr, Kachnic LA.

Clin Cancer Res. 2018 Aug 1;24(15):3500-3509. doi: 10.1158/1078-0432.CCR-17-3202. Epub 2018 Apr 16.

47.

Creation of Linear Carbon Dot Array with Improved Optical Properties through Controlled Covalent Conjugation with DNA.

Kumari S, Solanki A, Mandal S, Subramanyam D, Das P.

Bioconjug Chem. 2018 May 16;29(5):1500-1504. doi: 10.1021/acs.bioconjchem.8b00173. Epub 2018 Apr 12.

PMID:
29634254
48.

The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.

Bajaj A, Martin B, Bhasin R, Hentz C, Block AM, Harkenrider MM, Solanki AA.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):851-857. doi: 10.1016/j.ijrobp.2017.11.040. Epub 2017 Dec 5.

PMID:
29485062
49.

Cobalt-containing bioactive glasses reduce human mesenchymal stem cell chondrogenic differentiation despite HIF-1α stabilisation.

Littmann E, Autefage H, Solanki AK, Kallepitis C, Jones JR, Alini M, Peroglio M, Stevens MM.

J Eur Ceram Soc. 2018 Mar;38(3):877-886. doi: 10.1016/j.jeurceramsoc.2017.08.001.

50.

Evolving targets for the treatment of atherosclerosis.

Solanki A, Bhatt LK, Johnston TP.

Pharmacol Ther. 2018 Jul;187:1-12. doi: 10.1016/j.pharmthera.2018.02.002. Epub 2018 Feb 4. Review.

PMID:
29414673

Supplemental Content

Loading ...
Support Center